
TREAT-NMD is pleased to be represented on the board of the Medical Technology Group (MTG), with Alan Timothy representing the network.
The MTG brings together organisations committed to improving patient access to life-changing medical technologies. Through its work on NHS policy, innovation and patient outcomes, it aims to address barriers to access and support the adoption of technologies that can improve patients’ lives.
Alan Timothy shares:
“The Medical Technology Group (MTG) is the only UK coalition of patient groups, research charities, and medical device companies working together to ensure appropriate and timely patient access to medical technology.”
TREAT-NMD looks forward to contributing to the MTG’s work and supporting efforts to improve access to medical technologies and better outcomes for people living with neuromuscular diseases.
Find out more about the Medical Technology Group’s work on
NHS culture and innovation
.

